Abstract:Background. Studies that show common characteristics among ICU-admitted patients due to COVID-19 are available on the net, but such studies in Saudi Arabia are limited. Methods. A descriptive cross-sectional study establishing common comorbidities and risk factors among critically ill patients who tested positive for COVID-19 at the National Guard Hospital from March 2, 2020, to March 20, 2021. The data were obtained from the BEST Care System of King Abdulaziz Medical City, computed, and analyzed using SPSS. R… Show more
“…[19][20][21] Diabetes is thought to increase the incidence of respiratory illnesses, such as COVID-19, and can have a detrimental effect on the prognosis of patients with respiratory illnesses because chronic inflammation might impair the immune system. [22][23][24] Additionally, older people, who's poorer immunity makes them more susceptible to COVID-19, make up a sizable component of the Mexican population. 25,26 The relationship between COVID-19 and diabetes is a complex one, with both conditions impacting each other in multiple ways as found in many populational studies.…”
Section: Introductionmentioning
confidence: 99%
“…Obesity and hypertension are two comorbidities that are frequently present in diabetes patients and can raise the risk of respiratory problems 19‐21 . Diabetes is thought to increase the incidence of respiratory illnesses, such as COVID‐19, and can have a detrimental effect on the prognosis of patients with respiratory illnesses because chronic inflammation might impair the immune system 22‐24 . Additionally, older people, who's poorer immunity makes them more susceptible to COVID‐19, make up a sizable component of the Mexican population 25,26 …”
Background: Diabetes mellitus is a chronic health condition that has been linked with an increased risk of severe illness and mortality from COVID-19. In Mexico, the impact of diabetes on COVID-19 outcomes in hospitalized patients has not been fully quantified. Understanding the increased risk posed by diabetes in this patient population can help healthcare providers better allocate resources and improve patient outcomes. Objective: The objective of this study was to quantify the extent outcomes (pneumonia, intensive care unit [ICU] stay, intubation, and death) are worsened in diabetic patients with COVID-19. Methods: Between April 14, 2020 and December 20, 2020 (last accessed), data from the open-source COVID-19 database maintained by the Mexican Federal Government were examined. Utilizing hospitalized COVID-19 patients with complete outcome data, a retrospective cohort study (N = 402,388) was carried out. In relation to COVID-19, both univariate and multivariate logistic regression were used to investigate the effect of diabetes on specific outcomes. Results: The analysis included 402,388 adults (age >18) with confirmed hospitalized COVID-19 cases with mean age 46.16 (standard deviation = 15.55), 214,161 (53%) male. The outcomes delineated included pneumonia (N = 88,064; 22%), ICU
“…[19][20][21] Diabetes is thought to increase the incidence of respiratory illnesses, such as COVID-19, and can have a detrimental effect on the prognosis of patients with respiratory illnesses because chronic inflammation might impair the immune system. [22][23][24] Additionally, older people, who's poorer immunity makes them more susceptible to COVID-19, make up a sizable component of the Mexican population. 25,26 The relationship between COVID-19 and diabetes is a complex one, with both conditions impacting each other in multiple ways as found in many populational studies.…”
Section: Introductionmentioning
confidence: 99%
“…Obesity and hypertension are two comorbidities that are frequently present in diabetes patients and can raise the risk of respiratory problems 19‐21 . Diabetes is thought to increase the incidence of respiratory illnesses, such as COVID‐19, and can have a detrimental effect on the prognosis of patients with respiratory illnesses because chronic inflammation might impair the immune system 22‐24 . Additionally, older people, who's poorer immunity makes them more susceptible to COVID‐19, make up a sizable component of the Mexican population 25,26 …”
Background: Diabetes mellitus is a chronic health condition that has been linked with an increased risk of severe illness and mortality from COVID-19. In Mexico, the impact of diabetes on COVID-19 outcomes in hospitalized patients has not been fully quantified. Understanding the increased risk posed by diabetes in this patient population can help healthcare providers better allocate resources and improve patient outcomes. Objective: The objective of this study was to quantify the extent outcomes (pneumonia, intensive care unit [ICU] stay, intubation, and death) are worsened in diabetic patients with COVID-19. Methods: Between April 14, 2020 and December 20, 2020 (last accessed), data from the open-source COVID-19 database maintained by the Mexican Federal Government were examined. Utilizing hospitalized COVID-19 patients with complete outcome data, a retrospective cohort study (N = 402,388) was carried out. In relation to COVID-19, both univariate and multivariate logistic regression were used to investigate the effect of diabetes on specific outcomes. Results: The analysis included 402,388 adults (age >18) with confirmed hospitalized COVID-19 cases with mean age 46.16 (standard deviation = 15.55), 214,161 (53%) male. The outcomes delineated included pneumonia (N = 88,064; 22%), ICU
“…This article has been retracted by Hindawi following an investigation undertaken by the publisher [ 1 ]. This investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process: Discrepancies in scope Discrepancies in the description of the research reported Discrepancies between the availability of data and the research described Inappropriate citations Incoherent, meaningless and/or irrelevant content included in the article Peer-review manipulation …”
mentioning
confidence: 99%
“…This article has been retracted by Hindawi following an investigation undertaken by the publisher [1]. This investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process:…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.